Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference20 articles.
1. Sader, H. S., Huynh, H. K. & Jones, R. N. (2003). Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and β-lactams tested against gram-negative bacilli. Diagnostic Microbiology and Infectious Disease47, 547–50.
2. Mandal, S., Mandal, M. D. & Pal, N. K. (2003). Combination effect of ciprofloxacin and gentamicin against clinical isolates of Salmonella enterica serovar Typhi with reduced susceptibility to ciprofloxacin. Japanese Journal of Infectious Diseases56, 156–7.
3. Sweeney, M. T. & Zurenko, G. E. (2003). In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms. Antimicrobial Agents and Chemotherapy47, 1902–6.
4. Critchley, I. A., Sahm, D. F., Kelly, L. J. et al. (2003). In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli. Chemotherapy49, 44–8.
5. Jung, R., Husain, M., Choi, M. K. et al. (2004). Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrobial Agents and Chemotherapy48, 1055–7.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献